Patient and Physician Experiences in Immune Thrombocytopenia

Read full text
Authors: Andrew Hsu, Tammy Fassett, Steve Pallagi, Sandhya Ramanathan Panch
Cited by: 0
References: 42

Abstract

Immune thrombocytopenia (ITP) is a rare autoimmune disease that results in low platelet counts and an increased risk of spontaneous bleeding due to impaired blood clotting. Several therapeutic approaches can be used to treat patients with ITP. However, many patients either lose response in the long term or are unable to maintain a response after treatment discontinuation, necessitating chronic treatment and multiple lines of therapy. Here, two patients with ITP share their experience, each providing a firsthand description of their ITP diagnosis, symptoms, management, and perspectives on the future. These stories are complemented by a clinical review of ITP pathophysiology, symptoms, and treatments presented by two expert hematologists who care for patients with ITP. The physician perspective reinforces the challenges faced by patients in everyday life and highlights the remaining areas of concern regarding the treatment of chronic ITP.

Fields of Study & Subjects

Platelet Disorders and Treatments Heparin-Induced Thrombocytopenia and Thrombosis Hemophilia Treatment and Research

Publication details

Journal / source
Advances in Therapy
Volume
43
Issue
3
Pages
935–947
Publication date
27 January 2026
Language
EN